Amedisys, Inc. (NASDAQ: AMED) reported Q3 EPS of $0.33, $0.06 better than the analyst estimate of $0.27. Revenue for the quarter came in at $375.63 million versus the consensus estimate of $379.97 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.

Earnings